Quanta Therapeutics
Quanta Therapeutics is pioneering allosteric modulation to directly restore conformational control of active RAS signaling at the cell membrane to inhibit the full scope of RAS-driven cancer types.
$60M Series B+ ·
Led by Surveyor Capital · Source: precisiononcologynews.com
Latest round on record: Series B+, October 2026, amount undisclosed.
All 3 rounds ↓Signals
Quanta Therapeutics | 1847 days on the record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | — | quantatx.com | |
| Series B+ | undisclosed | fundraisingfox.com | ||
| Series B+ | $60M | precisiononcologynews.com |
Timeline
- Website created
Founders and team
CP
Cameron Pitt FounderJS
Joshua Salafsky FounderPN
Perry Nisen CEOVJ
Vanessa Jacoby Chief Business Officer and Chief Financial Officer
Investors
AAbbVie
AAvidity Partnerslead investor
BBiotechnology Value Fund
- GGC&H Investments
LLogos Capital
LLongitude Capital
SSofinnova Partners
SSurveyor Capitallead investor
VVida Ventureslead investor
- WWS Investment Company
Companies like Quanta Therapeutics
AAtavistik Bio$40M Series B+ · Mar 2026
HHotSpot Therapeutics$100M Series B+ · Nov 2021
AAccent Therapeutics$75M Series B+ · Jan 2024
AAsher Bio$55M Series B+ · Apr 2024
AA2 Biotherapeutics$80M Series B+ · Jan 2025
NNewLimit$435M Series B+ · Jun 2026
Other companies backed by Avidity Partners
SSirona Medical$40M Series B+ · Oct 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/quanta-therapeutics (get a free API key).